Skip to content

Effect of sodium reduction during lunch on consumer acceptance and on sodium intake

Effect of sodium reduction during lunch on consumer acceptance and on sodium intake - Sodium reduction during lunch

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36033
Enrollment
80
Registered
2011-04-29
Start date
2011-05-16
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

geen

Interventions

After the run-in period, sodium reduced lunch products are offered to the intervention group and to the control group regular products are offered during 3 weeks. Then all participants are offered s

Sponsors

Stichting DLO
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • age 18-35 years • BMI between 18.5 and 25 • apparently healthy based on their own judgment • consume at least four times a week lunch with bread and savory fillings (e.g. cold cuts, cheese) • indicate that they are willing to collect 24-hr urine for three separate days.

Exclusion criteria

Exclusion criteria: - food or sulfonamide allergy, vegetarian or specific diet - subject is not healthy. - BMI 25 -consume lunch with bread and savory fillings less than 4 times a week. -have participated in the breakfast study on salt reduction -Not signing informed consent -Student or employee of Division of Human Nutrition (Wageningen UR).

Design outcomes

Primary

MeasureTime frame
Number of times a food item is chosen, the consumption intake (in g and in Kcal ) and sodium intake (in mg), and 24-hr urinary total sodium measurement on three different days.

Secondary

MeasureTime frame
Questionnaire perception of offered products (taste, liking) (week 2, 5, 7) Questionnaireaim of the study (end week 5) Questionnaire lunch food choice and lunch habits (end week 7)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)